Joanna Wiensch
Stock Analyst at Citigroup
(2.09)
# 1108
Out of 5,368 analysts
31
Total ratings
73.68%
Success rate
20.79%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BDX Becton Dickinson | Downgrades: Neutral | 217 185 | 172.19 | 7.44% | 6 | May 22, 2025 | |
ABT Abbott Laboratories | Maintains: Strong Buy | 119 127 | 135.57 | -6.32% | 8 | Aug 22, 2024 | |
NVRO Nevro | Downgrades: Neutral | 40 | n/a | n/a | 1 | Jan 17, 2023 | |
DXCM DexCom | Maintains: Buy | 83 91 | 81.92 | 10.17% | 2 | Apr 29, 2020 | |
COO Cooper Companies | Maintains: Neutral | 90 80 | 69.59 | 14.24% | 2 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 120 | 143.89 | -16.6% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 200 | 256.6 | -22.06% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 40 | 97.72 | -59.07% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 168 | 91.28 | 84.05% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 63 | 86.19 | -26.91% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 235 | 377.25 | -37.71% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 220 | 304.5 | -27.75% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 68 | n/a | n/a | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 84 | 75.15 | 11.78% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 94 | 30.6 | 207.19% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 163 | 157.04 | 3.8% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 124 | 87.22 | 42.17% | 1 | Mar 5, 2020 |